Elevance Health, Inc
Held by 28 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 036752103 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 28 of the investors we track own this stock. In the latest quarter, 13 of them bought more of it and 13 sold some or all of theirs (4 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
28
+3 vs last quarter (like-for-like)
Total value held
$10.02B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
1.5%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$1.69B
+24.9% vs last quarter
Net shares bought
-1.3M
Est. net flow -$487.93M
Quarter activity
13 bought · 13 sold
4 new · 1 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns ELV?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns ELV? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↓ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 4 | Hotchkis & Wiley | Hotchkis & Wiley Capital Management | 2.02M | $779.73M | 2.3% | Reduced | -175.4K | -8.0% | -$67.82M |
| 5 | Jeremy Grantham | GMO | 1.69M | $654.22M | 1.5% | Reduced | -246.6K | -12.7% | -$95.37M |
| 7 | Baillie Gifford | Baillie Gifford & Co | 1.08M | $418.92M | 0.4% | Reduced | -89.6K | -7.6% | -$34.64M |
| 8 | Ruane Cunniff & Goldfarb | Sequoia Fund adviser | 979.60K | $378.84M | 5.9% | Reduced | -408.4K | -29.4% | -$157.93M |
| 9 | Glenn Greenberg | Brave Warrior Advisors | 976.88K | $377.79M | 8.2% | Reduced | -145.4K | -13.0% | -$56.24M |
| 10 | Ken Griffin | Citadel Advisors | 906.39K | $350.53M | 0.2% | Reduced | -655.8K | -42.0% | -$253.63M |
| 11 | Israel Englander | Millennium Management | 727.56K | $281.37M | 0.2% | Reduced | -191.6K | -20.8% | -$74.10M |
| 12 | Beutel Goodman | Beutel, Goodman & Co | 578.46K | $223.71M | 1.6% | Reduced | -308.3K | -34.8% | -$119.21M |
| 19 | Mawer | Mawer Investment Management | 187.29K | $72.43M | 0.5% | Reduced | -1.7K | -0.9% | -$660.53K |
| 22 | David Shaw | D.E. Shaw & Co. | 140.32K | $54.27M | 0.0% | Reduced | -265.7K | -65.4% | -$102.74M |
| 23 | Boston Partners | Boston Partners Global Investors | 137.41K | $53.21M | 0.0% | Reduced | -4.6K | -3.3% | -$1.80M |
| 27 | Ken Fisher | Fisher Asset Management | 1.61K | $623.32K | 0.0% | Reduced | -235 | -12.7% | -$90.93K |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Steve Cohen | Point72 Asset Management | -59.3K | $17.37M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Michael T. McCaul Politician | Oct 27, 2025 | ELV | ELEVANCE HEALTH INC scanned | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Nov 10, 2025 | 14 days | PTR ↗ |
| Lisa McClain Politician | Aug 13, 2025 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Sep 12, 2025 | 30 days | PTR ↗ |
| Michael T. McCaul Politician | Aug 21, 2025 | ELV | ELEVANCE HEALTH INC scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Sep 11, 2025 | 21 days | PTR ↗ |
| Lisa McClain Politician | Jun 24, 2025 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 50 days Late | PTR ↗ |
| Lisa McClain Politician | Jul 10, 2025 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 34 days | PTR ↗ |
| Jefferson Shreve Politician | May 12, 2025 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | CRT - Standard Unit Trust | Jun 22, 2025 | 41 days | PTR ↗ |
| Robert P. Bresnahan, Jr. Politician | May 15, 2025 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | JP Morgan Brokerage Account | May 31, 2025 | 16 days | PTR ↗ |
| Dan Newhouse Politician | Apr 11, 2025 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Edward Jones IRA | May 16, 2025 | 35 days | PTR ↗ |
| Jefferson Shreve Politician | Feb 24, 2025 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | CRT - Standard Unit Trust | Mar 9, 2025 | 13 days | PTR ↗ |
| Robert P. Bresnahan, Jr. Politician | Jan 13, 2025 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Joint Ownership LPL Account | Feb 13, 2025 | 31 days | PTR ↗ |
| Michael T. McCaul Politician | Nov 19, 2024 | ELV | ELEVANCE HEALTH INC scanned | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | — | — | Dec 16, 2024 | 27 days | PTR ↗ |
| Byron Donalds Politician | Aug 12, 2022 | ELV | Elevance Heath Inc (ELV) scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Nov 8, 2024 | 819 days Late | PTR ↗ |
| Byron Donalds Politician | Aug 12, 2022 | ELV | Elevance Heath Inc (ELV) scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Nov 8, 2024 | 819 days Late | PTR ↗ |
| Byron Donalds Politician | Oct 19, 2023 | ELV | Elevance Health Inc (ELV) scanned | Sale | — | — | — | — | Nov 8, 2024 | 386 days Late | PTR ↗ |
| Byron Donalds Politician | Oct 19, 2023 | ELV | Elevance Health Inc (ELV) scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Nov 8, 2024 | 386 days Late | PTR ↗ |
| John James Politician | Sep 4, 2024 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | John A. James Children’s Trust | Sep 6, 2024 | 2 days | PTR ↗ |
| John James Politician | Nov 10, 2023 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | John A. James Children’s Trust | Sep 2, 2024 | 297 days Late | PTR ↗ |
| John James Politician | Nov 16, 2023 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | John A. James Children’s Trust | Sep 2, 2024 | 291 days Late | PTR ↗ |
| Dan Newhouse Politician | Apr 10, 2024 | ELV | Elevance Health, Inc. Common Stock (ELV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Edward Jones IRA | Apr 25, 2024 | 15 days | PTR ↗ |